SEC Form 4 · accession 0001127602-19-008314

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Corporate Executive VP & CCO

Period of report

Feb 22, 2019

Accepted (ET)

Feb 26, 2019 · 2:41 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Feb 22, 2019	A	2,585	$0.00	A	29,330	D
Common Stock	Feb 23, 2019	F	316	$144.67	D	29,014	D
Common Stock	Feb 24, 2019	F	322	$144.67	D	28,692	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F2	$144.67	Feb 22, 2019	A	11,021	A	Feb 22, 2020	Feb 22, 2024	Common Stock	11,021	11,021	D

F1Consists of 2,585 unvested restricted stock units that vest as follows: 646 shares vest one (1) year from the date of issuance, 646 shares vest two (2) years from the date of issuance, 646 shares vest three (3) years from the date of issuance, and 647 shares vest four (4) years from the date of issuance.
F2Stock options vest as follows: 2,755 options vest one (1) year from the date of grant, 2,755 options vest two (2) years from the date of grant, 2,755 options vest three (3) years from the date of grant, and 2,756 options vest four (4) years from the date of grant.